Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody.

Yasugi M, Kubota-Koketsu R, Yamashita A, Kawashita N, Du A, Misaki R, Kuhara M, Boonsathorn N, Fujiyama K, Okuno Y, Nakaya T, Ikuta K.

PLoS One. 2013 Oct 16;8(10):e77892. doi: 10.1371/journal.pone.0077892. eCollection 2013.

PMID:
24147093
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.

Matsuzaki Y, Sugawara K, Nakauchi M, Takahashi Y, Onodera T, Tsunetsugu-Yokota Y, Matsumura T, Ato M, Kobayashi K, Shimotai Y, Mizuta K, Hongo S, Tashiro M, Nobusawa E.

J Virol. 2014 Nov;88(21):12364-73. doi: 10.1128/JVI.01381-14. Epub 2014 Aug 13.

PMID:
25122788
[PubMed - in process]
3.

[Detection of conservative and variable epitopes of the pandemic influenza virus A(H1N1)pdm09 hemagglutinin using monoclonal antibodies].

Masalova OV, Chichev EV, Fediakina IT, Mukasheva EA, Klimova RR, Shchelkanov MIu, Burtseva EI, Ivanova VT, Kushch AA, L'vov DK.

Vopr Virusol. 2014 May-Jun;59(3):34-40. Russian.

PMID:
25335417
[PubMed - indexed for MEDLINE]
4.

Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice.

O'Donnell CD, Vogel L, Wright A, Das SR, Wrammert J, Li GM, McCausland M, Zheng NY, Yewdell JW, Ahmed R, Wilson PC, Subbarao K.

MBio. 2012 May 29;3(3). pii: e00120-12. doi: 10.1128/mBio.00120-12. Print 2012.

PMID:
22647789
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties.

Strengell M, Ikonen N, Ziegler T, Julkunen I.

PLoS One. 2011;6(10):e25848. doi: 10.1371/journal.pone.0025848. Epub 2011 Oct 11.

PMID:
22022458
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.

Chen J, Yan B, Chen Q, Yao Y, Wang H, Liu Q, Zhang S, Wang H, Chen Z.

Arch Virol. 2014 Mar;159(3):471-83. doi: 10.1007/s00705-013-1852-y. Epub 2013 Sep 22.

PMID:
24057757
[PubMed - indexed for MEDLINE]
7.

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.

Schmeisser F, Friedman R, Besho J, Lugovtsev V, Soto J, Wang W, Weiss C, Williams O, Xie H, Ye Z, Weir JP.

Influenza Other Respir Viruses. 2013 May;7(3):480-90. doi: 10.1111/irv.12029. Epub 2012 Nov 5.

PMID:
23122228
[PubMed - indexed for MEDLINE]
8.

Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.

Guarnaccia T, Carolan LA, Maurer-Stroh S, Lee RT, Job E, Reading PC, Petrie S, McCaw JM, McVernon J, Hurt AC, Kelso A, Mosse J, Barr IG, Laurie KL.

PLoS Pathog. 2013;9(5):e1003354. doi: 10.1371/journal.ppat.1003354. Epub 2013 May 9.

PMID:
23671418
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays.

Huang JW, Lin WF, Yang JM.

Vaccine. 2012 Sep 28;30(44):6327-37. doi: 10.1016/j.vaccine.2012.07.079. Epub 2012 Aug 8.

PMID:
22885274
[PubMed - indexed for MEDLINE]
10.

Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin.

Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, Takada A.

PLoS One. 2010 Jan 1;5(1):e8553. doi: 10.1371/journal.pone.0008553.

PMID:
20049332
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.

Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Krylov PS, Webster RG.

J Virol. 2007 Dec;81(23):12911-7. Epub 2007 Sep 19.

PMID:
17881439
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.

Isolation of a high affinity neutralizing monoclonal antibody against 2009 pandemic H1N1 virus that binds at the 'Sa' antigenic site.

Shembekar N, Mallajosyula VV, Mishra A, Yeolekar L, Dhere R, Kapre S, Varadarajan R, Gupta SK.

PLoS One. 2013;8(1):e55516. doi: 10.1371/journal.pone.0055516. Epub 2013 Jan 31.

PMID:
23383214
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Molecular evolution of HA gene of the influenza A H1N1 pdm09 strain during the consecutive seasons 2009-2011 in Hangzhou, China: several immune-escape variants without positively selected sites.

Li J, Shao TJ, Yu XF, Pan JC, Pu XY, Wang HQ, Kou Y.

J Clin Virol. 2012 Dec;55(4):363-6. doi: 10.1016/j.jcv.2012.08.006. Epub 2012 Aug 22.

PMID:
22921413
[PubMed - indexed for MEDLINE]
15.

Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.

Liu X, Liu Y, Zhang Y, Chen Z, Tang Z, Xu Q, Wang Y, Zhao P, Qi Z.

PLoS One. 2013;8(3):e58810. doi: 10.1371/journal.pone.0058810. Epub 2013 Mar 19.

PMID:
23527030
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Antigenic variation of H1N1, H1N2 and H3N2 swine influenza viruses in Japan and Vietnam.

Takemae N, Nguyen T, Ngo LT, Hiromoto Y, Uchida Y, Pham VP, Kageyama T, Kasuo S, Shimada S, Yamashita Y, Goto K, Kubo H, Le VT, Van Vo H, Do HT, Nguyen DH, Hayashi T, Matsuu A, Saito T.

Arch Virol. 2013 Apr;158(4):859-76. doi: 10.1007/s00705-013-1616-8. Epub 2013 Feb 23.

PMID:
23435952
[PubMed - indexed for MEDLINE]
17.

The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.

Wu WL, Lau SY, Chen Y, Wang G, Mok BW, Wen X, Wang P, Song W, Lin T, Chan KH, Yuen KY, Chen H.

Antiviral Res. 2012 Jan;93(1):144-53. doi: 10.1016/j.antiviral.2011.11.006. Epub 2011 Nov 25.

PMID:
22138712
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).

Cabral TM, Berhane Y, Schmidt L, Tracz DM, Hole K, Leith M, Corbett CR.

J Virol Methods. 2012 Jul;183(1):25-33. doi: 10.1016/j.jviromet.2012.03.016. Epub 2012 Apr 4.

PMID:
22575685
[PubMed - indexed for MEDLINE]
19.

Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.

Yamashita A, Kawashita N, Kubota-Koketsu R, Inoue Y, Watanabe Y, Ibrahim MS, Ideno S, Yunoki M, Okuno Y, Takagi T, Yasunaga T, Ikuta K.

Biochem Biophys Res Commun. 2010 Mar 19;393(4):614-8. doi: 10.1016/j.bbrc.2010.02.031. Epub 2010 Feb 10.

PMID:
20152806
[PubMed - indexed for MEDLINE]
20.

Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal-Villán E, Palese P, Basler CF, García-Sastre A.

PLoS Pathog. 2010 Jan 29;6(1):e1000745. doi: 10.1371/journal.ppat.1000745.

PMID:
20126449
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk